Fundraising FoxRobin Hood Ventures — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Biomeme develops a mobile molecular testing platform that brings laboratory-grade PCR diagnostics to the point of need, serving clinical partners and organizations that need real-time detection of biological threats and diseases.
BiotechDigital HealthHealthtechMedical DevicesPhiladelphia, US
Max Perelman(President & Chief Executive Officer)inMarc DeJong(Executive Officer, Director)Jesse vanWestrienen(Executive Vice President of Products)inMarc DeJohn(Executive Officer, Director)inJesse van Westrienen(Executive Officer, Director)Chris Woods(Chief Medical Officer)in
PartnerPitou Devgon· solo GP
Co-investorsDarco CapitalFuture Communities CapitalNextFab VenturesMicroVentures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.